Arcturus partners with Thermo Fisher for ARCT-032 manufacturing.
Arcturus Therapeutics entered a strategic collaboration with Thermo Fisher Scientific to manufacture its cystic fibrosis candidate ARCT-032. This partnership accelerates development and secures late-stage manufacturing rights for the partner.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day